Adsorbing/dissolving Lyoprotectant Matrix Technology for Non-cryogenic Storage of Archival Human Sera

Despite abundant research conducted on cancer biomarker discovery and validation, to date, less than two-dozen biomarkers have been approved by the FDA for clinical use. One main reason is attributed to inadvertent use of low quality biospecimens in biomarker research. Most proteinaceous biomarkers...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2016-04, Vol.6 (1), p.24186-24186, Article 24186
Main Authors: Solivio, Morwena J., Less, Rebekah, Rynes, Mathew L., Kramer, Marcus, Aksan, Alptekin
Format: Article
Language:English
Subjects:
639/638/440/951
692/53/2421
82
82/1
82/51
Biomarkers
Blood Proteins - analysis
Cancer
Dextran
Heterogeneity
Humanities and Social Sciences
Humans
Matrilysin
multidisciplinary
Preservation, Biological - methods
Rehydration
Science
Serum - chemistry
Trehalose
Vitrification
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite abundant research conducted on cancer biomarker discovery and validation, to date, less than two-dozen biomarkers have been approved by the FDA for clinical use. One main reason is attributed to inadvertent use of low quality biospecimens in biomarker research. Most proteinaceous biomarkers are extremely susceptible to pre-analytical factors such as collection, processing and storage. For example, cryogenic storage imposes very harsh chemical, physical and mechanical stresses on biospecimens, significantly compromising sample quality. In this communication, we report the development of an electrospun lyoprotectant matrix and isothermal vitrification methodology for non-cryogenic stabilization and storage of liquid biospecimens. The lyoprotectant matrix was mainly composed of trehalose and dextran (and various low concentration excipients targeting different mechanisms of damage) and it was engineered to minimize heterogeneity during vitrification. The technology was validated using five biomarkers; LDH, CRP, PSA, MMP-7 and C3a. Complete recovery of LDH, CRP and PSA levels was achieved post-rehydration while more than 90% recovery was accomplished for MMP-7 and C3a, showing promise for isothermal vitrification as a safe, efficient and low-cost alternative to cryogenic storage.
ISSN:2045-2322
2045-2322
DOI:10.1038/srep24186